AREL1 anticorps (Middle Region)
Aperçu rapide pour AREL1 anticorps (Middle Region) (ABIN634861)
Antigène
Reactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Specificité
- KIAA0317 antibody was raised against the middle region of KIAA0317
-
Purification
- Affinity purified
-
Immunogène
- KIAA0317 antibody was raised using the middle region of KIAA0317 corresponding to a region with amino acids VRARFTRSFLAQIIGLRMHYKYFETDDPEFYKSKVCFILNNDMSEMELVF
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
KIAA0317 Blocking Peptide, (ABIN5614325), is also available for use as a blocking control in assays to test for specificity of this KIAA0317 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of KIAA0317 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- AREL1 (Apoptosis Resistant E3 Ubiquitin Protein Ligase 1 (AREL1))
-
Autre désignation
- KIAA0317
-
Sujet
- KIAA0317 contains 1 filamin repeat and 1 HECT (E6AP-type E3 ubiquitin-protein ligase) domain. The exact function of KIAA0317 remains unknown.
-
Poids moléculaire
- 94 kDa (MW of target protein)
Antigène
-